Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT in Acute Ischaemic Stroke
NCT03431402Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Randomised, open-label trial of hyperbaric oxygen therapy in ischemic stroke (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Change in National Institute of Health Stroke Score at 2 years. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03431402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431402.